These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 6655883)

  • 1. [Results of long-term administration of high-dose methotrexate and its pharmacokinetics in non-Hodgkin's lymphoma in children].
    Sasaki K; Fujimoto T; Shingaki Y; Hara T
    Rinsho Ketsueki; 1983 Feb; 24(2):96-103. PubMed ID: 6655883
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacokinetics of intermediate dose methotrexate in patients of non-Hodgkin's lymphoma and acute lymphocytic leukaemia.
    Gadgil SD; Damle SR; Shetty PA; Jussawalla DJ
    Indian J Cancer; 1980 Sep; 17(3):176-8. PubMed ID: 6936382
    [No Abstract]   [Full Text] [Related]  

  • 3. [Weekly high-dose methotrexate with citrovorum factor rescue for non-Hodgkin's lymphoma--serum methotrexate level and safety administration (author's transl)].
    Sasaki K; Fujimoto T; Goya N
    Rinsho Ketsueki; 1979 Jan; 20(1):90-7. PubMed ID: 311390
    [No Abstract]   [Full Text] [Related]  

  • 4. [Massive dose methotrexate with citrovorum factor rescue: MTX-pharmacokinetics, excretion pattern, and techniques for safety administration (author's transl)].
    Sasaki K; Fujimoto T
    Nihon Gan Chiryo Gakkai Shi; 1979 Oct; 14(6):988-96. PubMed ID: 317293
    [No Abstract]   [Full Text] [Related]  

  • 5. [Pharmacokinetics of intravenous methotrexate in children with neoplasms of the hematopoietic system].
    Hermann T; Skibińska L; Szwarc E; Michalewska D
    Pol Tyg Lek; 1984 May; 39(21):713-6. PubMed ID: 6592554
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of long-term neurocognitive outcomes in young children with acute lymphatic leukemia treated with cranial radiation or high-dose or very high-dose intravenous methotrexate.
    Cohen IJ
    J Clin Oncol; 2007 Feb; 25(6):734-5; author reply 735. PubMed ID: 17308283
    [No Abstract]   [Full Text] [Related]  

  • 7. Advanced-stage large-cell lymphoma in children and adolescents: results of a randomized trial incorporating intermediate-dose methotrexate and high-dose cytarabine in the maintenance phase of the APO regimen: a Pediatric Oncology Group phase III trial.
    Laver JH; Kraveka JM; Hutchison RE; Chang M; Kepner J; Schwenn M; Tarbell N; Desai S; Weitzman S; Weinstein HJ; Murphy SB
    J Clin Oncol; 2005 Jan; 23(3):541-7. PubMed ID: 15659500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of the methotrexate administration dose on the need for intrathecal treatment in children and adolescents with anaplastic large-cell lymphoma: results of a randomized trial of the EICNHL Group.
    Brugières L; Le Deley MC; Rosolen A; Williams D; Horibe K; Wrobel G; Mann G; Zsiros J; Uyttebroeck A; Marky I; Lamant L; Reiter A
    J Clin Oncol; 2009 Feb; 27(6):897-903. PubMed ID: 19139435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary non-Hodgkin's lymphoma of the CNS treated with CHOD/BVAM or BVAM chemotherapy before radiotherapy: long-term survival and prognostic factors.
    Bessell EM; Graus F; Lopez-Guillermo A; Lewis SA; Villa S; Verger E; Petit J
    Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):501-8. PubMed ID: 15145169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved outcome in children with advanced stage B-cell non-Hodgkin's lymphoma (B-NHL): results of the United Kingdom Children Cancer Study Group (UKCCSG) 9002 protocol.
    Atra A; Imeson JD; Hobson R; Gerrard M; Hann IM; Eden OB; Carter RL; Pinkerton CR
    Br J Cancer; 2000 Apr; 82(8):1396-402. PubMed ID: 10780517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequential multidrug chemotherapy (CHOP-VA-MB) in patients with high-grade non-Hodgkin's lymphoma--a 20-year follow-up.
    Björkholm M; Celsing F; Johansson E;
    Ann Hematol; 2006 Oct; 85(10):731-3. PubMed ID: 16838163
    [No Abstract]   [Full Text] [Related]  

  • 12. A phase II multicenter trial of high-dose sequential chemotherapy and peripheral blood stem cell transplantation as initial therapy for patients with high-risk non-Hodgkin's lymphoma.
    Schenkein DP; Roitman D; Miller KB; Morelli J; Stadtmauer E; Pecora AL; Cassileth P; Fernandez H; Cooper BW; Kutteh L; Lazarus HM
    Biol Blood Marrow Transplant; 1997 Oct; 3(4):210-6. PubMed ID: 9360783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prognostic changes in juvenile abdominal non-Hodgkin's lympomas (NHL)].
    Sigg C; Plüss HJ; Hitzig WH
    Schweiz Med Wochenschr; 1980 Jul; 110(27-28):1056-9. PubMed ID: 7423149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment results and prognostic significance of selected clinical and laboratory features in children diagnosed with malignant lymphoma].
    Kamieńska E
    Ann Acad Med Stetin; 1996; 42():105-22. PubMed ID: 9199116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of a massive dosage of methotrexate and leucovorin rescue therapy on acute leukemia and malignant lymphoma].
    Gan To Kagaku Ryoho; 1982 Mar; 9(3):421-32. PubMed ID: 6764106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-Hodgkin's lymphoma in patients with rheumatoid arthritis treated with low dose methotrexate.
    Usman AR; Yunus MB
    J Rheumatol; 1996 Jun; 23(6):1095-7. PubMed ID: 8782146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose sequential chemotherapy with autologous blood stem cell rescue for relapsed or resistant lymphoma.
    Sanna P; Van den Bosch S; Cavalli F; Ghielmini M
    Schweiz Med Wochenschr; 1998 Oct; 128(40):1500-7. PubMed ID: 9888164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [High dose methotrexate with leucovorin rescue in the treatment of malignant lymphoma].
    Sampi K; Hattori M
    Gan To Kagaku Ryoho; 1982 Jul; 9(6):1068-73. PubMed ID: 6985194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [High-dose chemotherapy in the treatment of children with malignant lymphoma].
    Kabícková E; Kavan P; Koutecký J; Malis J; Stanková J; Gajdos P; Kodet R; Cumlivská E
    Cas Lek Cesk; 2000 Oct; 139(20):623-9. PubMed ID: 11192757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MTHFR 677 (C-->T) polymorphism is not relevant for prognosis or therapy-associated toxicity in pediatric NHL: results from 484 patients of multicenter trial NHL-BFM 95.
    Seidemann K; Book M; Zimmermann M; Meyer U; Welte K; Stanulla M; Reiter A
    Ann Hematol; 2006 May; 85(5):291-300. PubMed ID: 16463153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.